Deutsche Bank Ag\ Affimed N.V. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.66 - $1.29 $68,438 - $133,765	-103,694 Reduced 53.0%	91,953 $68,000
Q4 2022 Feb 13, 2023	BUY	$1.1 - $2.45 $1,046 - $2,329	951 Added 0.49%	195,647 $242,000
Q3 2022 Nov 14, 2022	SELL	$1.96 - $3.32 $18,620 - $31,540	-9,500 Reduced 4.65%	194,696 $401,000
Q2 2022 Aug 11, 2022	BUY	$2.27 - $4.86 $7,677 - $16,436	3,382 Added 1.68%	204,196 $566,000
Q1 2022 May 13, 2022	SELL	$3.69 - $5.65 $26,940 - $41,250	-7,301 Reduced 3.51%	200,814 $878,000
Q4 2021 Feb 11, 2022	BUY	$5.37 - $7.07 $23,552 - $31,009	4,386 Added 2.15%	208,115 $1.15 Million
Q3 2021 Nov 04, 2021	SELL	$5.54 - $7.51 $271,753 - $368,388	-49,053 Reduced 19.41%	203,729 $1.26 Million
Q2 2021 Aug 11, 2021	BUY	$7.78 - $11.4 $1.36 Million - $1.99 Million	174,981 Added 224.91%	252,782 $2.15 Million
Q1 2021 May 13, 2021	BUY	$5.12 - $8.48 $61,009 - $101,047	11,916 Added 18.09%	77,801 $615,000
Q4 2020 Feb 16, 2021	SELL	$3.16 - $7.03 $3.59 Million - $7.98 Million	-1,134,796 Reduced 94.51%	65,885 $384,000
Q3 2020 Nov 12, 2020	BUY	$3.26 - $4.73 $3.79 Million - $5.5 Million	1,163,415 Added 3121.92%	1,200,681 $4.07 Million
Q2 2020 Aug 13, 2020	BUY	$1.58 - $4.63 $19,754 - $57,888	12,503 Added 50.49%	37,266 $172,000
Q1 2020 May 14, 2020	SELL	$1.44 - $3.02 $2,148 - $4,505	-1,492 Reduced 5.68%	24,763 $40,000
Q4 2019 Feb 14, 2020	BUY	$2.25 - $3.07 $19,793 - $27,006	8,797 Added 50.39%	26,255 $71,000
Q3 2019 Nov 14, 2019	SELL	$2.67 - $3.65 $134,306 - $183,602	-50,302 Reduced 74.24%	17,458 $50,000
Q2 2019 Aug 14, 2019	BUY	$2.6 - $4.21 $8,499 - $13,762	3,269 Added 5.07%	67,760 $194,000
Q1 2019 May 15, 2019	BUY	$3.05 - $4.34 $47,021 - $66,909	15,417 Added 31.42%	64,491 $270,000
Q4 2018 Feb 14, 2019	BUY	$2.82 - $4.67 $132,483 - $219,396	46,980 Added 2243.55%	49,074 $152,000
Q3 2018 Nov 14, 2018	BUY	$1.45 - $6.15 $2,856 - $12,115	1,970 Added 1588.71%	2,094 $8,000
Q2 2018 Aug 14, 2018	SELL	$1.65 - $2.5 $125,965 - $190,857	-76,343 Reduced 99.84%	124 $0
Q1 2018 May 15, 2018	BUY	$1.25 - $2.65 $58,458 - $123,932	46,767 Added 157.46%	76,467 $141,000
Q4 2017 Feb 14, 2018	SELL	$1.23 - $2.3 $60,640 - $113,392	-49,301 Reduced 62.41%	29,700 $38,000
Q3 2017 Nov 14, 2017	BUY	$1.95 - $2.25 $154,051 - $177,752	79,001	79,001 $177,000

Others Institutions Holding AFMD

# of Institutions

Shares Held

1.09M

Call Options Held

Put Options Held

View Full List

About Affimed N.V.

Ticker AFMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,339,008
Market Cap $185M
Description
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...

More about AFMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account